We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
Cap. Flow
-$307M
Cap. Flow %
-4.25%
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679

Sector Composition

Rank Sector Weight
1 Financials 12.25%
2 Industrials 9.66%
3 Utilities 9.48%
4 Technology 8.06%
5 Healthcare 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
2026
AstraZeneca
AZN
$241B
-285,144
Closed -$38.7M
BABA icon
2027
CALL
Alibaba
BABA
$309B
-100,000
Closed -$8.81M
BAX icon
2028
CALL
Baxter International
BAX
$14.7B
-9,100
Closed -$464K
BBWI icon
2029
CALL
Bath & Body Works
BBWI
$4.24B
-39,400
Closed -$1.66M
BDX icon
2030
PUT
Becton Dickinson
BDX
$46.9B
-3,700
Closed -$941K
BG icon
2031
CALL
Bunge Global
BG
$20.5B
-5,400
Closed -$539K
BG icon
2032
PUT
Bunge Global
BG
$20.5B
-7,600
Closed -$758K
BHC icon
2033
CALL
Bausch Health
BHC
$2.41B
-47,000
Closed -$295K
BHP icon
2034
PUT
BHP
BHP
$222B
-4,800
Closed -$298K
BJRI icon
2035
BJ's Restaurants
BJRI
$1.43B
-32,830
Closed -$866K
BNY
2036
CALL
Bank of New York Mellon
BNY
$106B
-6,200
Closed -$282K
BKE icon
2037
Buckle
BKE
$2.35B
-12,207
Closed -$554K
BLDR icon
2038
CALL
Builders FirstSource
BLDR
$8.11B
-4,300
Closed -$279K
BLUE
2039
DELISTED
bluebird bio
BLUE
-1,350
Closed -$187K
BMY icon
2040
CALL
Bristol-Myers Squibb
BMY
$135B
-5,800
Closed -$417K
BMY icon
2041
Bristol-Myers Squibb
BMY
$135B
-48,010
Closed -$3.45M
BMY icon
2042
PUT
Bristol-Myers Squibb
BMY
$135B
-14,600
Closed -$1.05M
BNL icon
2043
Broadstone Net Lease
BNL
$4.06B
-11,978
Closed -$194K
BP icon
2044
PUT
BP
BP
$109B
-207,400
Closed -$7.24M
BRBR icon
2045
BellRing Brands
BRBR
$1.48B
-9,589
Closed -$246K
BRKR icon
2046
Bruker
BRKR
$7.66B
-3,939
Closed -$269K
BSX icon
2047
PUT
Boston Scientific
BSX
$71.1B
-15,100
Closed -$699K
BTM
2048
DELISTED
Bitcoin Depot
BTM
-89,286
Closed -$6.34M
BV icon
2049
BrightView Holdings
BV
$1.22B
-13,000
Closed -$89.6K
BX icon
2050
Blackstone
BX
$110B
-7,858
Closed -$583K

Similar funds

Verition Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.

  • Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
  • Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
  • Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
  • Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
  • Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
  • Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
  • Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.